Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02349711 · ClinicalTrials.gov registry record · NA

Probiotics and Health-related Quality of Life in Individuals With Seasonal Allergies

A NA study, sponsored by University of Florida.

Completed
Registry status
NA
Development phase
224
Enrollment target

NCT02349711: Completed NA study, sponsored by University of Florida.

NCT02349711 is a NA study that has completed, run by University of Florida. The registered enrollment target is 224 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02349711, a NA study, has completed, sponsored by University of Florida.

COMPLETED
Registry status
NA
Development phase
224 participants
Enrollment target

Study Summary

In this randomized, double-blind, placebo-controlled study, participants with seasonal allergies will receive a daily probiotic or placebo for 8 weeks. Questionnaires will assess health-related quality of life, stress, physical activity, gastrointestinal symptoms, adverse events, and compliance. In a subset of subjects, stool and blood samples will be collected at baseline and at week 6 of the intervention (estimated to be peak allergy season) to characterize microbial communities and immune function.

Primary Outcome

MiniRQLQ, global score (0=not troubled, 6=extremely troubled; an average of the 14 questions; includes all domains)

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Probiotic mixture

Trial Details

FieldValue
Enrollment Target 224 participants
Start Date 2015-01
Est. Completion 2015-05
Phase NA
University of Florida

1,106 total trials

What the finished NCT02349711 record still lists

NCT02349711 is an interventional study that assigns participants to a tested intervention. The registered 224 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT02349711 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02349711 about?

NCT02349711 is a clinical study titled "Probiotics and Health-related Quality of Life in Individuals With Seasonal Allergies". In this randomized, double-blind, placebo-controlled study, participants with seasonal allergies will receive a daily probiotic or placebo for 8 weeks. Questionnaires will assess health-related quality of life, stress, physical activity, gastrointestinal symptoms, adverse events, and compliance. In ...

What is the current status of trial NCT02349711?

This trial is currently completed. It is a NA study. The enrollment target is 224 participants. The study started on 2015-01. Estimated completion is 2015-05.

What interventions are being tested in trial NCT02349711?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Probiotic mixture (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT02349711?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02349711's enrollment target sits among peer trials

224 478th of 2000 higher than 1,520 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02706561 · 224 participants · NA

    Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery

  • NCT04140344 · 224 participants · NA

    The NOTICE Study: Neurosurgery and OrThopedIcs Communication Evaluation Study Following Lumbar Fusions

  • NCT04915183 · 224 participants · Phase 2

    Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

  • NCT05519878 · 224 participants · NA

    Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02349711, the US trial registry maintained by the National Library of Medicine. NCT02349711 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.